• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 5. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzene and substituted derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives

Professional Introduction to Compound with CAS No. 881838-90-0 and Product Name: 2-(4-hexylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane)

Compound with the CAS number 881838-90-0 and the product name 2-(4-hexylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound belongs to the class of boron-containing heterocycles, which are widely recognized for their versatile applications in synthetic chemistry, particularly in cross-coupling reactions. The unique structural features of this molecule, including its tetramethyl-substituted dioxaborolane core and the 4-hexylphenyl substituent, make it a valuable intermediate in the synthesis of complex organic molecules.

The tetramethyl-substituted dioxaborolane core of this compound enhances its stability and reactivity, making it an excellent candidate for use in palladium-catalyzed cross-coupling reactions such as Suzuki-Miyaura coupling. These reactions are fundamental in the construction of biaryl compounds, which are prevalent in many pharmaceuticals and agrochemicals. The presence of the 4-hexylphenyl group introduces steric bulk and lipophilicity to the molecule, which can be strategically employed to modulate the pharmacokinetic properties of derivatives synthesized from this compound.

In recent years, there has been a surge in research focused on developing novel boron-containing heterocycles for medicinal applications. The dioxaborolane moiety is particularly interesting because it can be easily functionalized through metal-catalyzed borylation reactions, allowing for the introduction of diverse substituents at specific positions. This flexibility has made compounds like 2-(4-hexylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane) indispensable in drug discovery pipelines.

One of the most compelling aspects of this compound is its potential utility in the development of next-generation therapeutics. Researchers have been exploring its use as a precursor for synthesizing small-molecule inhibitors targeting various biological pathways. For instance, derivatives derived from this compound have shown promise in inhibiting enzymes involved in cancer metabolism. The 4-hexylphenyl group can be tailored to optimize binding affinity and selectivity against specific enzyme targets, while the boronate functionality allows for further derivatization through transition-metal catalysis.

The synthesis of 2-(4-hexylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane) involves multi-step organic transformations that highlight its synthetic utility. The process typically begins with the preparation of a suitable boronic acid precursor followed by protection with a tetramethyl-substituted dioxaborolane group. The introduction of the 4-hexylphenyl moiety is achieved through selective functionalization techniques such as lithiation followed by quenching with a hexyl halide. This synthetic route underscores the compound's role as a building block in complex molecule construction.

Advances in computational chemistry have further enhanced our understanding of how this compound behaves in various chemical environments. Molecular modeling studies have revealed that the tetramethyl-substituted dioxaborolane core influences electron density distribution across the molecule, affecting its reactivity in cross-coupling reactions. Additionally, the steric influence of the 4-hexylphenyl group can be fine-tuned to modulate interactions with biological targets. These insights have guided medicinal chemists in designing more effective derivatives with improved pharmacological profiles.

In conclusion,2-(4-hexylphenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane) (CAS No. 881838-90-0) represents a significant advancement in boron-containing heterocyclic chemistry. Its unique structural features and synthetic versatility make it an invaluable tool for pharmaceutical research and development. As our understanding of its reactivity and biological interactions continues to grow,this compound is poised to play a pivotal role in the discovery and synthesis of novel therapeutic agents that address unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)